ENA Respiratory announced preparations for a Phase 2b study of its INNA-051 pegylated TLR2/6 agonist nasal spray for the prevention of respiratory viruses in people aged 65 and older will be supported by an additional $3.8 million from the US Department of Defense (DOD) as well as by several new clinical appointments. In January 2023, the company said that it had … [Read more...] about ENA Respiratory announces new funding, personnel to support Phase 2b study of INNA-051 antiviral nasal spray
People
Avalyn names Howard M. Lazarus as Chief Medical Officer
Avalyn Pharma, which is developing inhaled formulations of pirfenidone and nintedanib for the treatment of pulmonary fibrosis, has announced the appointment of former Altavant Sciences Chief Medical Officer Howard M. Lazarus as Chief Medical Officer. Lazarus's previous positions include Medical Expert/Executive Director in Clinical Development and Medical Affairs at … [Read more...] about Avalyn names Howard M. Lazarus as Chief Medical Officer
Resyca announces new Chief Technical Officer, licensing deal with Thaerapy
Soft mist inhaler developer Resyca, a joint venture of Medspray Pharma and Recipharm, has announced the promotion of current Head of Development and Project Management Nicolas Buchmann to Chief Technical Officer. Buchman will take over from Wilbur de Kruijf, who is leaving to serve as CEO of a start-up inhaled drug developer called Thaerapy. Resyca also announced that … [Read more...] about Resyca announces new Chief Technical Officer, licensing deal with Thaerapy
Tiziana announces the promotion of Matthew Davis to Chief Operating Officer
Intranasal foralumab developer Tiziana Life Sciences announced the promotion of its Chief Medical Officer Matthew Davis to Chief Operating Officer. Davis, who joined Tiziana in July 2022, will continue to serve as Chief Medical Officer in addition to his role as COO. His previous experience includes roles at Endo, Lupin, and URL Pharma. According to the company, … [Read more...] about Tiziana announces the promotion of Matthew Davis to Chief Operating Officer
Aerami Therapeutics announces appointment of interim CEO and additional management positions
Aerami Therapeutics has announced the promotion of Joshua Ziel from Chief of Staff and VP, Program Development to Chief Operating Officer and interim CEO. Executive Chairwoman Anne Whitaker had been leading Aerami since the sudden death of CEO Lisa Yañez in May 2023. The company also announced the appointments of Gary Burgess as Chief Medical Officer and Sarah … [Read more...] about Aerami Therapeutics announces appointment of interim CEO and additional management positions
MannKind names Burkhard Blank as Executive VP, R&D, and Chief Medical Officer
Inhaled drug developer MannKind Corporation has announced the appointment of former Acorda Therapeutics Head of R&D and Chief Medical Officer Burkhard Blank as MannKind's new Executive VP, Research & Development, and Chief Medical Officer. At Acorda, he was responsible for Phase 3 development of Inbrija levodopa inhalation powder. Blank was most recently Head … [Read more...] about MannKind names Burkhard Blank as Executive VP, R&D, and Chief Medical Officer
Copley Scientific hires Clair Brooks as Applications Specialist
Inhaler testing equipment maker Copley Scientific has announced the appointment of Clair Brooks as Applications Specialist "to maintain a customer-centric focus as growth continues." Brooks was most recently a field application specialist at Primerdesign, a maker of PCR kits. Copley Managing Director Jamie Clayton commented, "The role of applications specialist … [Read more...] about Copley Scientific hires Clair Brooks as Applications Specialist
Following the sudden death of CEO Lisa Yañez, Anne Whitaker will lead Aerami
Aerami Therapeutics has issued a statement following the death of CEO Lisa Yañez, who was killed in a car accident on May 2, 2023 in Chapel Hill, NC, USA, offering condolences to Yañez's family and announcing that former CEO and current Executive Chairwoman Anne Whitaker will assume leadership of the company. Yañez joined Aerami in June 2022 as Chief Operating … [Read more...] about Following the sudden death of CEO Lisa Yañez, Anne Whitaker will lead Aerami
ReCode Therapeutics hires John G. Matthews as Senior VP of Clinical Development
ReCode Therapeutics, which is developing inhaled mRNA therapeutics for the treatment of primary ciliary dyskinesia and cystic fibrosis, has named John G. Matthews as Senior VP of Clinical Development. ReCode initiated a Phase 1 trial of its RCT1100 nebulized DNAI1 mRNA in March 2023. A pulmonologist, Matthews has extensive experience in respiratory disease research … [Read more...] about ReCode Therapeutics hires John G. Matthews as Senior VP of Clinical Development
Gunilla Petersson joins HCmed as Chief Scientific Officer
HCmed Innovations announced that former AstraZeneca Science and Innovation Director of Inhaled Drug Delivery Gunilla Petersson has joined the company as Chief Scientific Officer. Petersson has almost 30 years of experience in the pharmaceutical industry, primarily in inhaled drug development. Taipei-based HCmed launched the Pulmogine handheld mesh nebulizer in … [Read more...] about Gunilla Petersson joins HCmed as Chief Scientific Officer